Video

Q&A With Vincenzo La Mura From University of Milan: Applicability of Non-Selective Beta Blockers in the Elderly

Author(s):

A social problem with limited existing research, work has been done to understand the risks and benefits associated with administering non-selective beta blockers to elderly patients.

A social problem with limited existing research, Vincenzo La Mura, MD, University of Milan, and his colleagues hoped to understand the risks and benefits associated with administering non-selective beta blockers to elderly patients.

La Mura was one of the speakers when the European Association for the Study of the Liver held its 50th Annual Liver Conference in Vienna.

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
Orly Vardeny, PharmD | Credit: JACC Journals
© 2024 MJH Life Sciences

All rights reserved.